| Name | Title | Contact Details |
|---|
Lindenhurst Park District is located in northwestern Lake County, Illinois. The District was formed in March, 1988, making us one of the youngest Park Districts in this area.
The International Center of Photography (ICP) is a prominent institution focused on photography and visual culture, founded in 1974 by photojournalist Cornell Capa. Located in New York Citys Lower East Side, ICP serves as a center for exhibitions, education, and public engagement, highlighting the significance of photography in contemporary society. ICP promotes "concerned photography," which emphasizes socially and politically driven imagery aimed at fostering global change. The center curates rotating exhibitions that showcase both historical and contemporary works, drawing from its extensive archives. It also offers educational programs, serving over 3,000 students annually through various courses and workshops in photography, filmmaking, and visual storytelling. Additionally, ICP engages the public through lectures, symposia, and community events that explore the societal role of photography. ICP targets students, artists, educators, and photography enthusiasts, providing tailored programs for aspiring professionals and lifelong learners. Its mission is to advance photography as a tool for social change and cultural dialogue, solidifying its position as a leader in visual arts education and exhibition.
At Gate City Bank, we invest in the best people...driven people, compassionate people, creative people…people like you! We invest in the best team members because its whats best for our customers. We are investing in our team members with competitive compensation and comprehensive benefits packages, along with promoting a fun, family-friendly work environment. Gate City Bank is a mutual community bank and we have been providing complete banking services to our customers since 1923. It is Gate City Banks privilege to be a hometown bank that provides excellent service that is convenient, friendly, and personalized. We are proud to be the #1 mortgage lender in North Dakota with locally approved and financed home loans. Gate City Bank is also unique in offering our checking customers FREE ATMs anywhere with unlimited ATM fee refunds, which has saved our customers more than $33 million since we began refunding ATM fees in 2006. Thats what its all about here at Gate City Bank - making your financial life easier, more convenient, and more rewarding so you can enjoy a better way of life. Gate City Bank is honored to support our communities through charitable contributions, in-kind donations such as reduced interest-rate loans for non-profit organizations, and paid volunteer time for our team members. We go beyond our commitment to offering the best checking, savings, and loan programs – were touching lives in the communities we serve. With 43 locations across North Dakota and central Minnesota, Gate City Bank shares a commitment to our customers, communities, and team members. Member FDIC - Equal Housing Lender - EOE, including Disability/Vets
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.